Literature DB >> 24516048

The function of the RNA-binding protein hnRNP in cancer metastasis.

Na Han, Wentao Li, Mengxian Zhang1.   

Abstract

Heterogeneous ribonucleoproteins (hnRNPs) are involved in a variety of key cellular functions and are most likely involved in different steps of pre-mRNA processing. Over the past decades, the central roles of hnRNPs have been detected, which show that they are involved in RNA splicing, telomere biogenesis, DNA repair, cell signaling, and in transcription and translation. Mounting evidence suggests that they are involved in the regulation of mRNA stability and translation in many cancer types. The hnRNPs have a variety of potential roles in inhibition of apoptosis, angiogenesis, cell invasion, and epithelial-mesenchymal transition (EMT). It is thus suggested that hnRNP might be a novel and promising therapeutic target and a marker for treatment response and prognostic evaluation. The aims of this review are to survey the existing evidence and discuss the diverse functions of hnRNPs in cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24516048     DOI: 10.4103/0973-1482.122506

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  28 in total

Review 1.  Avoiding hepatic metastasis naturally: Lessons from the cotton top tamarin (Saguinus oedipus).

Authors:  Martin Tobi; Peter Thomas; Daniel Ezekwudo
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Modulation of the Hippo pathway and organ growth by RNA processing proteins.

Authors:  Jana Mach; Mardelle Atkins; Kathleen M Gajewski; Violaine Mottier-Pavie; Leticia Sansores-Garcia; Jun Xie; Robert Andrew Mills; Weronika Kowalczyk; Leen Van Huffel; Gordon B Mills; Georg Halder
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-26       Impact factor: 11.205

3.  Downregulated Poly-C binding protein-1 is a novel predictor associated with poor prognosis in Acute Myeloid Leukemia.

Authors:  Meifeng Zhou; Xiuzhen Tong
Journal:  Diagn Pathol       Date:  2015-08-21       Impact factor: 2.644

Review 4.  RNA-Binding Proteins: Splicing Factors and Disease.

Authors:  Alger M Fredericks; Kamil J Cygan; Brian A Brown; William G Fairbrother
Journal:  Biomolecules       Date:  2015-05-13

5.  Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexes.

Authors:  Annalisa Rossi; Albertomaria Moro; Toma Tebaldi; Nicola Cornella; Lisa Gasperini; Lorenzo Lunelli; Alessandro Quattrone; Gabriella Viero; Paolo Macchi
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

6.  Expression of hnRNPK & Claudin-4 in HCV-Induced Early HCC and Adjacent Liver Tissue.

Authors:  Olfat Hammam; Mona Magdy; Amgad Anas; Ali Abdel Rahim; Mohamed Heedaya; Ahmed Helmy
Journal:  Open Access Maced J Med Sci       Date:  2017-07-31

7.  Metformin treatment reduces temozolomide resistance of glioblastoma cells.

Authors:  Seung Ho Yang; Shenglan Li; Guangrong Lu; Haipeng Xue; Dong H Kim; Jay-Jiguang Zhu; Ying Liu
Journal:  Oncotarget       Date:  2016-11-29

Review 8.  Unraveling the mysteries of serum albumin-more than just a serum protein.

Authors:  Angelica M Merlot; Danuta S Kalinowski; Des R Richardson
Journal:  Front Physiol       Date:  2014-08-12       Impact factor: 4.566

9.  Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis.

Authors:  Peng Dai; Qin Wang; Weihua Wang; Ruirui Jing; Wei Wang; Fengqin Wang; Kazem M Azadzoi; Jing-Hua Yang; Zhen Yan
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

Review 10.  A summary of relationships between alternative splicing and breast cancer.

Authors:  Zhang Xiping; Wei Qingshan; Zhao Shuai; Yang Hongjian; Ding Xiaowen
Journal:  Oncotarget       Date:  2017-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.